» Authors » Kaname Yoshizawa

Kaname Yoshizawa

Explore the profile of Kaname Yoshizawa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 102
Citations 1765
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hitomi Y, Ueno K, Aiba Y, Nishida N, Kono M, Sugihara M, et al.
Hepatology . 2024 Apr; 80(4):776-790. PMID: 38652555
Background And Aims: Previous genome-wide association studies (GWAS) have indicated the involvement of shared (population-nonspecific) and nonshared (population-specific) susceptibility genes in the pathogenesis of primary biliary cholangitis (PBC) among European...
2.
Migita K, Nakamura M, Aiba Y, Kozuru H, Abiru S, Komori A, et al.
PLoS One . 2020 Dec; 15(12):e0238540. PMID: 33347507
Background: Autoimmune hepatitis (AIH) is a disorder of unknown etiology in which immune-mediated liver injury progress to cirrhosis or hepatocellular carcinoma (HCC). The aim of the present study was to...
3.
Takahashi A, Ohira H, Abe K, Zeniya M, Abe M, Arinaga-Hino T, et al.
Sci Rep . 2020 Aug; 10(1):14250. PMID: 32859968
The Japanese diagnostic guidelines for autoimmune hepatitis (AIH) were proposed in 2014. This study aimed to determine the trends and characteristics of AIH based on a Japanese nationwide survey. Data...
4.
Takahashi A, Ohira H, Abe K, Zeniya M, Abe M, Arinaga-Hino T, et al.
Med Mol Morphol . 2020 May; 54(1):8-13. PMID: 32410010
Histopathology is essential for the diagnosis and evaluation of disease activity of autoimmune hepatitis (AIH). We aimed to elucidate the characteristics of AIH from the localization of inflammation. We re-evaluated...
5.
Ueno K, Aiba Y, Hitomi Y, Shimoda S, Nakamura H, Gervais O, et al.
Hepatol Commun . 2020 May; 4(5):724-738. PMID: 32363322
Genome-wide association studies (GWASs) in European and East Asian populations have identified more than 40 disease-susceptibility genes in primary biliary cholangitis (PBC). The aim of this study is to computationally...
6.
Sugiura A, Joshita S, Yamashita Y, Yamazaki T, Fujimori N, Kimura T, et al.
Biomedicines . 2020 Apr; 8(4). PMID: 32260271
Glecaprevir/pibrentasvir (G/P) are direct-acting antivirals (DAAs) that achieve a high sustained virological response (SVR) rate for hepatitis C virus (HCV) infection. We investigated G/P effectiveness for HCV patients based on...
7.
Umemura T, Joshita S, Saito H, Yoshizawa K, Norman G, Tanaka E, et al.
JHEP Rep . 2020 Feb; 1(5):353-360. PMID: 32039386
Methods: A total of 154 cases of AIH were recruited at Shinshu University Hospital between 1974 and 2018. KIR genes and HLA class I and II alleles were genotyped in...
8.
Matsuoka N, Kozuru H, Koga T, Abiru S, Yamasaki K, Komori A, et al.
Medicine (Baltimore) . 2019 Aug; 98(35):e16924. PMID: 31464928
Autoimmune hepatitis (AIH) is a disorder of unknown etiology in which immune-mediated liver damage progresses to cirrhosis or hepatocellular carcinoma (HCC). The mainstay therapy for AIH is steroids and other...
9.
Higuchi T, Oka S, Furukawa H, Nakamura M, Komori A, Abiru S, et al.
Sci Rep . 2019 May; 9(1):7925. PMID: 31138864
Autoimmune hepatitis (AIH) is an autoimmune liver disease and cirrhosis is sometimes complicated with AIH at diagnosis, influencing its prognosis. TNFAIP3 gene encodes A20, an inhibitor of nuclear factor-κB pathway,...
10.
Hitomi Y, Ueno K, Kawai Y, Nishida N, Kojima K, Kawashima M, et al.
Sci Rep . 2019 Jan; 9(1):102. PMID: 30643196
Primary biliary cholangitis (PBC) is a chronic and cholestatic autoimmune liver disease caused by the destruction of intrahepatic small bile ducts. Our previous genome-wide association study (GWAS) identified six susceptibility...